284 related articles for article (PubMed ID: 24450344)
21. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Preoperative Chemotherapy with Modified OPTIMOX-1 Plus Bevacizumab in Patients with Advanced Rectal Cancer with Factors Contraindicative of Curative Surgery.
Kosugi C; Koda K; Tanaka K; Suzuki M; Yamazaki M; Shuto K; Matsuo K; Hirano A; Arimitsu H; Shiragami R; Yasuda H
Hepatogastroenterology; 2015 Jun; 62(140):868-72. PubMed ID: 26902018
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma.
Shamseddine A; Zeidan YH; El Husseini Z; Kreidieh M; Al Darazi M; Turfa R; Kattan J; Khalifeh I; Mukherji D; Temraz S; Alqasem K; Amarin R; Al Awabdeh T; Deeba S; Jamali F; Mohamad I; Elkhaldi M; Daoud F; Al Masri M; Dabous A; Hushki A; Jaber O; Charafeddine M; Geara F
Radiat Oncol; 2020 Oct; 15(1):233. PubMed ID: 33028346
[TBL] [Abstract][Full Text] [Related]
24. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
[TBL] [Abstract][Full Text] [Related]
25. Abdominosacral resection: long-term outcome in 86 patients with locally advanced or locally recurrent rectal cancer.
Bosman SJ; Vermeer TA; Dudink RL; de Hingh IH; Nieuwenhuijzen GA; Rutten HJ
Eur J Surg Oncol; 2014 Jun; 40(6):699-705. PubMed ID: 24679359
[TBL] [Abstract][Full Text] [Related]
26. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Vestermark LW; Jensen HA; Pfeiffer P
Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
[TBL] [Abstract][Full Text] [Related]
27. Does pathologic response of rectal cancer influence postoperative morbidity after neoadjuvant radiochemotherapy and total mesorectal excision?
Maggiori L; Bretagnol F; Aslam MI; Guedj N; Zappa M; Ferron M; Panis Y
Surgery; 2014 Mar; 155(3):468-75. PubMed ID: 24439750
[TBL] [Abstract][Full Text] [Related]
28. [A case of metastatic rectal cancer in an extremely aged patient successfully treated with mFOLFOX6 plus bevacizumab].
Yokoyama M; Urakawa M; Murakami T; Amano K; Ohsawa T; Okada N; Kumamoto K; Ishibashi K; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2241-3. PubMed ID: 22202342
[TBL] [Abstract][Full Text] [Related]
29. Laparoscopic total pelvic exenteration with en bloc lateral lymph node dissection after neoadjuvant chemoradiotherapy for advanced primary rectal cancer.
Mukai T; Akiyoshi T; Ueno M; Fukunaga Y; Nagayama S; Fujimoto Y; Konishi T; Ikeda A; Yamaguchi T
Asian J Endosc Surg; 2013 Nov; 6(4):314-7. PubMed ID: 24308593
[TBL] [Abstract][Full Text] [Related]
30. Outcome of abdominosacral resection for locally advanced primary and recurrent rectal cancer.
Bhangu A; Brown G; Akmal M; Tekkis P
Br J Surg; 2012 Oct; 99(10):1453-61. PubMed ID: 22961529
[TBL] [Abstract][Full Text] [Related]
31. Circumferential resection margin involvement after laparoscopic abdominoperineal excision for rectal cancer.
Raftopoulos I; Reed JF; Bergamaschi R
Colorectal Dis; 2012 Apr; 14(4):431-7. PubMed ID: 21689315
[TBL] [Abstract][Full Text] [Related]
32. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of neoadjuvant chemotherapy with XELOX plus bevacizumab for locally advanced rectal cancer.
Uehara K; Ishiguro S; Sakamoto E; Maeda A; Inoue M; Tojima Y; Kobayashi S; Omiya N; Ishizuka N; Nakao A; Goto H; Nagino M
Jpn J Clin Oncol; 2011 Aug; 41(8):1041-4. PubMed ID: 21803876
[TBL] [Abstract][Full Text] [Related]
34. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of preoperative radiotherapy or chemoradiotherapy in sphincter preservation for locally advanced middle-low rectal cancer].
Cao WG; Zhao R; Xi WQ; Ma T; Li H; Xu HP; Che JF; Jin YN
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):225-7. PubMed ID: 17649643
[TBL] [Abstract][Full Text] [Related]
36. [A long-term survival case of rectal cancer with Virchow's lymph node metastasis by multimodality therapy].
Hirose H; Ikeda M; Miyoshi N; Kim HM; Okano M; Uemura M; Yamashita S; Takemasa I; Mizushima T; Yamamoto H; Ishii H; Sekimoto M; Doki Y; Mori M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2545-7. PubMed ID: 21224634
[TBL] [Abstract][Full Text] [Related]
37. [Surgical resection after chemotherapy for advanced rectal cancer - report of a case].
Suda K; Kameyama H; Shimada Y; Sakata J; Kobayashi T; Nogami H; Minagawa M; Kosugi S; Koyama Y; Wakai T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1572-4. PubMed ID: 25731256
[TBL] [Abstract][Full Text] [Related]
38. What is the incidence of metastatic lymph node involvement after significant pathologic response of primary tumor following neoadjuvant treatment for locally advanced rectal cancer?
Tranchart H; Lefèvre JH; Svrcek M; Flejou JF; Tiret E; Parc Y
Ann Surg Oncol; 2013 May; 20(5):1551-9. PubMed ID: 23188545
[TBL] [Abstract][Full Text] [Related]
39. [A case of advanced colon cancer successfully treated with combination therapy of cetuximab and oxaliplatin, leucovorin, and 5-fluorouracil].
Ojima E; Nakano T; Kanamoto A; Sasaki S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1962-4. PubMed ID: 24393980
[TBL] [Abstract][Full Text] [Related]
40. [A case of advanced rectal cancer that showed complete response to the addition of XELOX+bevacizumab therapy to preoperative chemoradiotherapy with S-1/CPT-11].
Takahashi T; Namiki K; Matsumoto H; Konno F; Mitsui K; Yoshida R
Gan To Kagaku Ryoho; 2014 May; 41(5):653-5. PubMed ID: 24917016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
